Pharmaceutical News and Articles

Policy Statement Updates Guidelines on Pediatric Drowning Prevention

Multiple layers of drowning prevention should be emphasized by pediatricians, according to a policy statement and accompanying technical report published online

ATS: Tezepelumab Reduces Asthma Exacerbations Across Asthma Phenotypes

For patients with severe, uncontrolled asthma, tezepelumab is associated with substantial reductions in asthma exacerbations across asthma phenotypes and underr

FDA Approves Baxfendy (baxdrostat) as the First Aldosterone Synthase Inhibitor Treatment for Adults with Hypertension

Femoral BMD, Osteoporosis Linked to All-Cause Mortality Postmenopause

Femoral bone mineral density (BMD) and osteoporosis are associated with all-cause mortality in postmenopausal women, according to a study published online May 1

Chronic Rhinosinusitis Linked to Culture Positivity for Pseudomonas in Bronchiectasis

For individuals with bronchiectasis, a history of chronic rhinosinusitis (CRS) is associated with culture positivity for Pseudomonas aeruginosa (P. aeruginosa),

New-Onset A-Fib May Accelerate Kidney Function Decline

New-onset atrial fibrillation (AF) may accelerate kidney function decline, according to a study published online May 14 in JAMA Network Open. Yuichiro Mori, M.D

Pregnancy Not Linked to Myasthenia Gravis Exacerbations

Pregnancy is not associated with an increased risk for myasthenia gravis (MG) exacerbations, according to a study published online May 13 in Neurology. Laura O

ATS: City-Wide Mold Intervention Can Reduce ED Asthma Visits

A city-wide mold intervention in public housing can reduce asthma emergency department (ED) visits, according to a study presented at the American Thoracic Soci

Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings

MONDAY, May 18, 2026 The World Health Organization (WHO) has declared an ebola outbreak in the Democratic Republic of Congo (DRC) an international public health

Single Psilocybin Dose Provides Rapid Relief From Depression, Small Clinical Trial Finds

MONDAY, May 18, 2026 Just a single dose of psilocybin can provide rapid relief from depression, a new small-scale clinical trial has shown.Within a week, people